ES2148268T3 - Composicion farmaceutica para prevenir o tratar fracturas de huesos. - Google Patents

Composicion farmaceutica para prevenir o tratar fracturas de huesos.

Info

Publication number
ES2148268T3
ES2148268T3 ES94117339T ES94117339T ES2148268T3 ES 2148268 T3 ES2148268 T3 ES 2148268T3 ES 94117339 T ES94117339 T ES 94117339T ES 94117339 T ES94117339 T ES 94117339T ES 2148268 T3 ES2148268 T3 ES 2148268T3
Authority
ES
Spain
Prior art keywords
prevent
pharmaceutical composition
bone fractures
treat bone
fractures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94117339T
Other languages
English (en)
Inventor
Masayoshi Koyama
Mikiko Takahashi
Kazuyuki Doi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Application granted granted Critical
Publication of ES2148268T3 publication Critical patent/ES2148268T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UNA COMPOSICION FARMACEUTICA PARA PREVENIR O TRATAR LAS FRACTURAS OSEAS QUE COMPRENDE COMO INGREDIENTE ACTIVO UN FACTOR 4 DE LAS PLAQUETAS. LA COMPOSICION PUEDE PROMOVER LA DIFERENCIACION DE LOS OSTEOBLASTOS DE MANERA QUE SEAN EFECTIVOS PARA LA PROFILAXIS Y EL TRATAMIENTO DE ENFERMEDADES QUE REQUIERAN LA DIFERENCIACION Y PROLIFERACION DEL HUESO TALES COMO LAS FRACTURAS Y SIMILARES.
ES94117339T 1993-11-05 1994-11-02 Composicion farmaceutica para prevenir o tratar fracturas de huesos. Expired - Lifetime ES2148268T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5276473A JPH07126181A (ja) 1993-11-05 1993-11-05 骨折の予防および治療剤

Publications (1)

Publication Number Publication Date
ES2148268T3 true ES2148268T3 (es) 2000-10-16

Family

ID=17569945

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94117339T Expired - Lifetime ES2148268T3 (es) 1993-11-05 1994-11-02 Composicion farmaceutica para prevenir o tratar fracturas de huesos.

Country Status (12)

Country Link
US (1) US5622935A (es)
EP (1) EP0655251B1 (es)
JP (1) JPH07126181A (es)
KR (1) KR100313980B1 (es)
AT (1) ATE193450T1 (es)
AU (1) AU7762594A (es)
CA (1) CA2135123A1 (es)
DE (1) DE69424747T2 (es)
DK (1) DK0655251T3 (es)
ES (1) ES2148268T3 (es)
GR (1) GR3034161T3 (es)
PT (1) PT655251E (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726538B2 (en) * 1993-11-05 2000-11-09 Hoechst Japan Limited Pharmaceutical composition for increasing differentiation of osteoblasts
CN1108169C (zh) * 1999-06-24 2003-05-14 中国医学科学院血液学研究所 一种用于辐射损伤治疗的多肽类药物组合物
CN1196480C (zh) * 2001-07-03 2005-04-13 北京巨能亚太生命科学研究中心 L－苏糖酸钙在制备预防或治疗骨折的药物中的用途
WO2005065704A1 (ja) * 2004-01-09 2005-07-21 Saitama Medical School 骨疾患の予防および治療剤
JP2008239488A (ja) * 2005-07-07 2008-10-09 Saitama Medical Univ 動脈硬化の治療剤
US8367112B2 (en) * 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
JP7071724B2 (ja) * 2017-08-24 2022-05-19 国立大学法人大阪大学 骨配向化用薬剤組成物、及び骨疾患治療薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009301A1 (en) * 1990-11-27 1992-06-11 The American National Red Cross Tissue sealant and growth factor containing compositions that promote accelerated wound healing
US5304542A (en) * 1992-08-28 1994-04-19 University Of Louisville Research Foundation, Inc. Use of platelet factor 4 to inhibit osteoblast proliferation

Also Published As

Publication number Publication date
EP0655251B1 (en) 2000-05-31
DE69424747T2 (de) 2000-11-09
CA2135123A1 (en) 1995-05-06
KR100313980B1 (ko) 2002-02-19
GR3034161T3 (en) 2000-11-30
DE69424747D1 (de) 2000-07-06
EP0655251A1 (en) 1995-05-31
JPH07126181A (ja) 1995-05-16
DK0655251T3 (da) 2000-10-09
US5622935A (en) 1997-04-22
KR950013519A (ko) 1995-06-15
ATE193450T1 (de) 2000-06-15
AU7762594A (en) 1995-05-18
PT655251E (pt) 2000-10-31

Similar Documents

Publication Publication Date Title
DE69732170D1 (de) Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
ES2088006T3 (es) Composiciones farmaceuticas osteoinductivas.
ES2064130T3 (es) Utilizacion de droloxifeno para el tratamiento de enfermedades de los huesos.
IL100100A0 (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
MXPA02005173A (es) Composicion farmaceutica para el tratamiento de enfermedades asociadas con disminucion de masa osea.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2063033T3 (es) Empleo de igf-ii en el tratamiento de la enfermedades de los huesos.
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
FI951856A0 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
ES2174921T3 (es) Inhibidores de la proteasa del vih.
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
ES2148268T3 (es) Composicion farmaceutica para prevenir o tratar fracturas de huesos.
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
CO4520283A1 (es) Agentes antivirales
SE9001308D0 (sv) Foerfarande foer att behandla och foerebygga foertvining av bensubstans
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
ES2059204T3 (es) Derivados del acido hidroxamico inhibidores de lipoxigenasa.
GB9505082D0 (en) Medicament
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ES2155223T3 (es) 1-naftoilguanidinas sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
DE69932434D1 (de) Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten
MX9301108A (es) Uso de un compuesto antagonista de serotonina para la fabricacion de un medicamento para promover la cicatrizacion de heridas, composicion que contiene dicho medicamento, y metodo para prepararla.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 655251

Country of ref document: ES